49 Comments
 

As someone that's in the industry, PJT and Evercore are in their own bucket. Don't think the other commentors disagreeing actually work in restructuring. 80+% of big / important restructurings and LMEs will have one advising the company and the other advising the fulcrum. 

Disclaimer: I did two years as analyst in one of those groups, worked on more than a dozen deals and worked across from the other firm on literally every single one. 

HL / Moelis / Guggenheim still have a presence / will see them on some MM sponsor backed situations. Centerview and Lazard will sometimes win big debtor corporate mandates bc of strong M&A relationships. 

Pretty much everybody at PJT and Evercore really only consider the other as the best comp / a true peer and respect each other and their professionals a lot.   

 

To the people saying congrats on EVR! You clearly have no idea what you’re talking about. Evercore or PJT are on literally everything, it’s actually absurd. They dominate compared to HL, LAZ, MOE, PWP, etc.

PJT > EVR > HL > LAZ, MOE, PWP > etc

 

WTF is Perella doing in T2? It should be with Ducera, Greenhil, Guggenheim, which all have great RX groups btw. I'm sorry, but Perella is not in Moelis' or Lazard's tier

 
Most Helpful

Don't know if it's the same guy that keeps commenting "congrats on EVR" over and over again but if you are in RX it's PJT EVR top 2. They are the major drivers on the vast majority of notable LMEs. You can just start googling "liability management transaction" if you want to check for yourself.

Below this it is slightly harder to tier IMO. E.g. HL/Moelis on average probably sits above PWP, Gugg, Laz, but the latter definitely have a number of engagements that are better than a lot at the former.

Just saying this for any prospects so you know RX is not as binary as M&A with strictly defined categories by market cap (i.e. who you end up working with in the group can often times make a bigger difference than the actual firm you are at - in my humble opinion).

For T3 / the good non-EBs this is even more true, e.g. MB, Jefferies, Piper/TRS. Apparently some of these groups are like 20 people so when you adjust for group size they're actually punching pretty heavy above their weight and probably get great reps too

 

100% agree that who you’re staffed under matters way more than the bank.

I would rather be at Guggenheim under a competent MD working on debtor work than HL grinding out retard UCC engagements (not at either of those shops).

Find the man that brings in the dough and latch yourself to him if you eventually want to be a rainmaker.

 

Funny that you mentioned LME yet LAZ was literally advising on the J Crew dropdown. EVR has a strong momentum, I'll give you that. But it's still closer to LAZ/MOE/HL RX than to PJT RSSG. No clue why you're grouping GUGG and PWP with LAZ. They definitely don't have the track record of LAZ in RX (feels like LAZ is being "punished" here due to recent changes in the group's management, which is fair) 

 

Think historically it was Lazard (J. Crew, PG&E, Lehman, Argentina + every other sovereign rx), until EVR/PJT popped up

 

This is not a ranking at all but here's a decently comprehensive list of firms that do RX:

EBs: Evercore PJT, Greenhill, PWP, Moelis, Lazard ,Ducera, Guggenheim (???), Centerview Partners

MMs: Piper Sandler (Formerly TRS advisors has an RX office in Boston), Houlihan Lokey, Duff & Phelps (Kroll), Rothschild, Oppenheimer, Miller Buckfire, Baird

Consulting: Alvarez & Marsal,  FTI Consulting, Deloitte EY-Parthenon, PwC (Business Recovery Services)

Random boutiques: Gordian Group, Capstone Partners, etc.

If you only want to network at the top RX firms like Evercore, PJT, Lazard, or whatever else is considered “top,” go do that, but remember this is a pretty niche part of an already small area of the financial services space. So, I’d recommend networking far and wide with firms that do RX.

 

Currently an Asso2 at an EB (not LAZ or EVR). No one considers EVR to be on par with PJT RSSG. They are bucketed with MOE / LAZ / HL, and while they had a strong 1-2 years, they are not suddenly on par with PJT because of that  

 

It’s PJT and Evercore at 1 and 2 and everyone else below. Whoever keeps saying EVR isn’t top 1 or 2 is clearly not in the industry. It almost seems like PJT/EVR are on opposite sides of every single high profile mandate recently. It’s kind of crazy.

Source: Work at laz/moe/gugg rx so visibility is quite high…

 

WHY THE HELL HAS NO ONE MENTIONED BAIRD!! I used to work there during my analyst years (currently senior associate at BB (BofA, MS, RBC)). During my time we couldn't catch a break from the amount of Rx engagements we got. I was in a different group, but my closest mentor was a rx director at the time. If you want experience in this field there are few better shops than Baird.

 

Doloribus exercitationem beatae velit quasi et. Maxime placeat laborum fuga natus est culpa excepturi. Culpa quae enim soluta corporis tenetur enim.

Enim nisi qui expedita. Placeat ipsam debitis eius commodi voluptatem placeat rem. Id voluptate facere quaerat velit possimus tenetur. Ea minima atque dolorum nam. Dolorem occaecati possimus numquam quas architecto labore velit.

Qui reprehenderit consequatur eius est aliquam repudiandae quae et. Qui maxime consequatur aut nesciunt vel quibusdam. Enim beatae voluptatibus nemo voluptatem quia.

 

Reiciendis vel id voluptate recusandae a corrupti. Eos itaque fugit eos nisi doloremque excepturi nesciunt non. Qui aut quisquam aut. Voluptatem doloremque sit qui eum iste in aperiam enim. Laborum nostrum earum illum cum. Est quis ad voluptatem placeat.

Tenetur vel et in ut quia quod. Odio nam assumenda praesentium aliquam omnis cum incidunt. Non aspernatur et enim corporis voluptas necessitatibus.

 

Accusantium consequuntur nesciunt a quidem rerum eum. Ad aliquam error est dolor et autem et.

Odio ullam id consequatur ut mollitia. Quasi quod aut eos.

Voluptas laudantium neque rerum ut laborum perspiciatis ea. Aliquid mollitia soluta et cum. Repellat consequatur maxime aut officia ipsam. A neque accusantium nostrum.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 04 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (17) $409
  • Associates (58) $261
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (77) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Secyh62's picture
Secyh62
99.0
4
kanon's picture
kanon
99.0
5
DrApeman's picture
DrApeman
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”